Functional Significance of CD133 in Pancreatic Cancer

Project: Research project

Description

Pancreatic ductal adenocarcinoma (PDAC) is currently the fourth most frequent cause of cancer related deaths in United States due to propensity to metastasis, invasion and resistance to chemotherapy. All stage 5-year survival rate is
StatusActive
Effective start/end date4/1/14 → 3/30/20

Funding

  • National Institutes of Health: $318,513.00
  • National Institutes of Health: $315,400.00
  • National Institutes of Health: $318,513.00
  • National Institutes of Health: $318,513.00
  • National Institutes of Health: $315,400.00
View all
View less

Fingerprint

Pancreatic Neoplasms
Adenocarcinoma
Neoplasm Metastasis
Drug Therapy
Neoplasms